Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

MHEA announces new President MHEA announces new President Two additions to NSF International’s Pharma Biotech Service Two additions to NSF International’s Pharma Biotech Service Outpost Medicine appoints Scott Byrd as CEO Outpost Medicine appoints Scott Byrd as CEO Realm Therapeutics appoints Sandy Zweifach as non-executive director Realm Therapeutics appoints Sandy Zweifach as non-executive director New appointments enhance PAREXEL’s leadership and expertise New appointments enhance PAREXEL’s leadership and expertise Christine Banaszek appointed Sales Manager at Charles Ross & Son Christine Banaszek appointed Sales Manager at Charles Ross & Son British Biosimilars Association appoints new chair Kavya Gopal British Biosimilars Association appoints new chair Kavya Gopal Pertinax Pharma appoints Nigel Brooksby as Chairman Pertinax Pharma appoints Nigel Brooksby as Chairman Needham Coding appoints new Inkjet Systems Manager Needham Coding appoints new Inkjet Systems Manager Evox Therapeutics appoints Antonin de Fougerolles as CEO Evox Therapeutics appoints Antonin de Fougerolles as CEO DuPont Scientist Philippe Horvath receives Franklin Institute prize DuPont Scientist Philippe Horvath receives Franklin Institute prize Ubichem invests in business-critical technical pharma capability Ubichem invests in business-critical technical pharma capability Almac Group appointment of Victor Diaz as Head of Physical Sciences Almac Group appointment of Victor Diaz as Head of Physical Sciences STORM Therapeutics strengthens board with appointment of Professor Paul Workman STORM Therapeutics strengthens board with appointment of Professor Paul Workman Zelluna Immunotherapy appoints Miguel Forte as CEO Zelluna Immunotherapy appoints Miguel Forte as CEO Topas Therapeutics appoints new Chief Development Officer Topas Therapeutics appoints new Chief Development Officer Adgero Biopharmaceuticals appoints John Liatos as CFO Adgero Biopharmaceuticals appoints John Liatos as CFO Michael Sherman joins BioVie Board of Directors Michael Sherman joins BioVie Board of Directors Somic adds Luke Gardner to sales team Somic adds Luke Gardner to sales team Tekni-Plex promotes Glenn Fish to COO Tekni-Plex promotes Glenn Fish to COO Dr Istvan Udvaros joins Cristal Therapeutics as new Chief Medical Officer Dr Istvan Udvaros joins Cristal Therapeutics as new Chief Medical Officer Concept Life Sciences appoints Philip Payne as Chief Commercial Officer Concept Life Sciences appoints Philip Payne as Chief Commercial Officer BES appoints Gavin Statham as Business Development Director BES appoints Gavin Statham as Business Development Director Sobi establishes new leadership structure and appoints Torbjorn Hallberg as General Counsel Sobi establishes new leadership structure and appoints Torbjorn Hallberg as General Counsel
  • Previous
  • 1
  • …
  • 40
  • 41
  • 42
  • 43 (current)
  • 44
  • 45
  • 46
  • …
  • 141
  • Next

Trending Articles

  1. THX Pharma appoints Julien Veys as deputy chief executive officer Leadership appointment supports the company’s strategy to advance regulatory approval and commercialization of rare neurology therapies
  2. Kindeva announces leadership transition to support strategic growth David Stevens assumes CEO role as part of a planned succession strategy
  3. Astoriom appoints Will Edwards as Chief Executive Officer Strategic appointment to support global scale-up of sample management operations
  4. Rentschler Biopharma appoints Detra Glinatsis as head of U.S. business development Glinatsis returns to lead U.S. growth strategy and build on Milford site expansion
  5. Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO Appointment supports NanoSyrinx’s transition from platform development to clinical-stage intracellular medicines

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.